Literature DB >> 6592146

Inhibition of rheumatoid factor production by non-steroidal anti-inflammatory drugs.

J S Goodwin, J L Ceuppens, M A Rodriguez.   

Abstract

The effects of NSAIDs on IgM rheumatoid factor production in vitro and on serum rheumatoid factor concentration in vivo were investigated using indomethacin (5.0 micrograms/ml), carprofen (10 micrograms/ml). IgM rheumatoid factor was isolated from lymphocytes of patients suffering from rheumatoid arthritis. NSAIDs inhibited IgM rheumatoid factor production in vitro. Furthermore, serum IgM rheumatoid factor was reduced when NSAIDs were administered in vivo. It is thought that NSAIDs effectively remove suppressor T-cells from the tonic inhibitory action of PGE2. This previously unrecognized action of NSAIDs may be a factor in their efficacy in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6592146     DOI: 10.1007/bf00915712

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  4 in total

1.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

2.  Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity.

Authors:  J L Ceuppens; J S Goodwin
Journal:  Cell Immunol       Date:  1982-06       Impact factor: 4.868

3.  Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro.

Authors:  J L Ceuppens; M A Rodriguez; J S Goodwin
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

4.  Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels.

Authors:  J S Goodwin; J L Ceuppens; M A Rodriguez
Journal:  JAMA       Date:  1983-11-11       Impact factor: 56.272

  4 in total
  3 in total

1.  Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.

Authors:  B Cardario; A A McKinnon
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

Review 2.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

3.  Non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Effects on clinical parameters and cellular immunity.

Authors:  O Førre; J Thoen; K Helgetveit; Y Haile
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.